Clinical trial · Interventional

Radiation Therapy or Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma

Hodgkin's Disease Study

NCT00416377CI-TRIAL-00011546unknownN/AClinicalTrials.gov clinicaltrialsPublishedExplore in graph →

Summary

Brief summary (as posted)

RATIONALE: Radiation therapy uses high-energy x-rays to kill cancer cells. Drugs used in chemotherapy work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more cancer cells. PURPOSE: This clinical trial is studying how well radiation therapy or combination chemotherapy work in treating young patients with Hodgkin's lymphoma.

Conditions

Conditions (1)

Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.

Condition (as posted)	Mapped entity	Match	Confidence
Lymphoma	Lymphoma	ONTOLOGY_EXACT	0.90

Interventions

Interventions (9)

Intervention	Type	Mapped drug	Match
bleomycin sulfate	Biological	Bleomycin	ALIAS
chlorambucil	Drug	Chlorambucil	ALIAS
dacarbazine	Drug	Dacarbazine	ALIAS
doxorubicin hydrochloride	Drug	Doxorubicin	ALIAS
prednisolone	Drug	Prednisolone	ALIAS
procarbazine hydrochloride	Drug	Procarbazine	ALIAS
radiation therapy	Radiation	—	UNRESOLVED
vinblastine sulfate	Drug	Vinblastine	ALIAS

Eligibility

Eligibility (as posted)

Sex: All

Show eligibility criteria text

DISEASE CHARACTERISTICS:

* Histologically confirmed childhood Hodgkin's lymphoma by lymph node biopsy

  * Any stage disease
  * Patients with bilateral upper cervical disease with no evidence of supraclavicular, thoracic inlet, or Waldeyers ring involvement are treated as having stage I disease

PATIENT CHARACTERISTICS:

* Platelet count \> 100,000/mm\^3
* Absolute neutrophil count \> 1,000/mm\^3

PRIOR CONCURRENT THERAPY:

* Not specified

References

Publications (0)

Data not yet available

No reference posted for this study.